Selected research
Industry Research
Parasiticide for Animal Industry Research Report 2026
Market perspective
The global Parasiticide for Animal market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Parasiticide for Animal is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Parasiticide for Animal is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Parasiticide for Animal is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Parasiticide for Animal include Novartis AG, Merck & Co., Eli Lilly, Bayer AG, Zoetis, Virbac SA, Vetoquinol., Ceva Sante Animlae and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Parasiticide for Animal market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Parasiticide for Animal Market by Company
Novartis AG
Merck & Co.
Eli Lilly
Bayer AG
Zoetis
Virbac SA
Vetoquinol.
Ceva Sante Animlae
Boehringer Ingelheim
Parasiticide for Animal Segment by Type
Ectoparasiticides
Endoparasiticides
Parasiticide for Animal Segment by Application
Food-producing Animals
Companion Animals
Parasiticide for Animal Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parasiticide for Animal market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Parasiticide for Animal and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parasiticide for Animal.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Parasiticide for Animal manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Parasiticide for Animal by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Parasiticide for Animal in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Ectoparasiticides
- Endoparasiticides
Applications
- Food-producing Animals
- Companion Animals
Companies covered
- Novartis AG
- Merck & Co.
- Eli Lilly
- Bayer AG
- Zoetis
- Virbac SA
- Vetoquinol.
- Ceva Sante Animlae
- Boehringer Ingelheim
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Parasiticide for Animal Market Size (2021-2032)
- 2.2.2 Global Parasiticide for Animal Sales (2021-2032)
- 2.2.3 Global Parasiticide for Animal Market Average Price (2021-2032)
- 2.3 Parasiticide for Animal by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Ectoparasiticides
- 2.3.3 Endoparasiticides
- 2.4 Parasiticide for Animal by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Food-producing Animals
- 2.4.3 Companion Animals
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Parasiticide for Animal Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Parasiticide for Animal Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Parasiticide for Animal Revenue of Manufacturers (2021-2026)
- 3.4 Global Parasiticide for Animal Average Price by Manufacturers (2021-2026)
- 3.5 Global Parasiticide for Animal Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Parasiticide for Animal, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Parasiticide for Animal, Product Type & Application
- 3.8 Global Manufacturers of Parasiticide for Animal, Established Date
- 3.9 Global Parasiticide for Animal Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novartis AG
- 4.1.1 Novartis AG Company Information
- 4.1.2 Novartis AG Business Overview
- 4.1.3 Novartis AG Parasiticide for Animal Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novartis AG Parasiticide for Animal Product Portfolio
- 4.1.5 Novartis AG Recent Developments
- 4.2 Merck & Co.
- 4.2.1 Merck & Co. Company Information
- 4.2.2 Merck & Co. Business Overview
- 4.2.3 Merck & Co. Parasiticide for Animal Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Merck & Co. Parasiticide for Animal Product Portfolio
- 4.2.5 Merck & Co. Recent Developments
- 4.3 Eli Lilly
- 4.3.1 Eli Lilly Company Information
- 4.3.2 Eli Lilly Business Overview
- 4.3.3 Eli Lilly Parasiticide for Animal Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Eli Lilly Parasiticide for Animal Product Portfolio
- 4.3.5 Eli Lilly Recent Developments
- 4.4 Bayer AG
- 4.4.1 Bayer AG Company Information
- 4.4.2 Bayer AG Business Overview
- 4.4.3 Bayer AG Parasiticide for Animal Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Bayer AG Parasiticide for Animal Product Portfolio
- 4.4.5 Bayer AG Recent Developments
- 4.5 Zoetis
- 4.5.1 Zoetis Company Information
- 4.5.2 Zoetis Business Overview
- 4.5.3 Zoetis Parasiticide for Animal Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Zoetis Parasiticide for Animal Product Portfolio
- 4.5.5 Zoetis Recent Developments
- 4.6 Virbac SA
- 4.6.1 Virbac SA Company Information
- 4.6.2 Virbac SA Business Overview
- 4.6.3 Virbac SA Parasiticide for Animal Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Virbac SA Parasiticide for Animal Product Portfolio
- 4.6.5 Virbac SA Recent Developments
- 4.7 Vetoquinol.
- 4.7.1 Vetoquinol. Company Information
- 4.7.2 Vetoquinol. Business Overview
- 4.7.3 Vetoquinol. Parasiticide for Animal Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Vetoquinol. Parasiticide for Animal Product Portfolio
- 4.7.5 Vetoquinol. Recent Developments
- 4.8 Ceva Sante Animlae
- 4.8.1 Ceva Sante Animlae Company Information
- 4.8.2 Ceva Sante Animlae Business Overview
- 4.8.3 Ceva Sante Animlae Parasiticide for Animal Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Ceva Sante Animlae Parasiticide for Animal Product Portfolio
- 4.8.5 Ceva Sante Animlae Recent Developments
- 4.9 Boehringer Ingelheim
- 4.9.1 Boehringer Ingelheim Company Information
- 4.9.2 Boehringer Ingelheim Business Overview
- 4.9.3 Boehringer Ingelheim Parasiticide for Animal Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Boehringer Ingelheim Parasiticide for Animal Product Portfolio
- 4.9.5 Boehringer Ingelheim Recent Developments
5 Global Parasiticide for Animal Market Scenario by Region
- 5.1 Global Parasiticide for Animal Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Parasiticide for Animal Sales by Region: 2021-2032
- 5.2.1 Global Parasiticide for Animal Sales by Region: 2021-2026
- 5.2.2 Global Parasiticide for Animal Sales by Region: 2027-2032
- 5.3 Global Parasiticide for Animal Revenue by Region: 2021-2032
- 5.3.1 Global Parasiticide for Animal Revenue by Region: 2021-2026
- 5.3.2 Global Parasiticide for Animal Revenue by Region: 2027-2032
- 5.4 North America Parasiticide for Animal Market Facts & Figures by Country
- 5.4.1 North America Parasiticide for Animal Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Parasiticide for Animal Sales by Country (2021-2032)
- 5.4.3 North America Parasiticide for Animal Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Parasiticide for Animal Market Facts & Figures by Country
- 5.5.1 Europe Parasiticide for Animal Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Parasiticide for Animal Sales by Country (2021-2032)
- 5.5.3 Europe Parasiticide for Animal Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Parasiticide for Animal Market Facts & Figures by Country
- 5.6.1 Asia Pacific Parasiticide for Animal Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Parasiticide for Animal Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Parasiticide for Animal Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Parasiticide for Animal Market Facts & Figures by Country
- 5.7.1 South America Parasiticide for Animal Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Parasiticide for Animal Sales by Country (2021-2032)
- 5.7.3 South America Parasiticide for Animal Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Parasiticide for Animal Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Parasiticide for Animal Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Parasiticide for Animal Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Parasiticide for Animal Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Parasiticide for Animal Sales by Type (2021-2032)
- 6.1.1 Global Parasiticide for Animal Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Parasiticide for Animal Sales Market Share by Type (2021-2032)
- 6.2 Global Parasiticide for Animal Revenue by Type (2021-2032)
- 6.2.1 Global Parasiticide for Animal Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Parasiticide for Animal Revenue Market Share by Type (2021-2032)
- 6.3 Global Parasiticide for Animal Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Parasiticide for Animal Sales by Application (2021-2032)
- 7.1.1 Global Parasiticide for Animal Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Parasiticide for Animal Sales Market Share by Application (2021-2032)
- 7.2 Global Parasiticide for Animal Revenue by Application (2021-2032)
- 7.2.1 Global Parasiticide for Animal Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Parasiticide for Animal Revenue Market Share by Application (2021-2032)
- 7.3 Global Parasiticide for Animal Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Parasiticide for Animal Value Chain Analysis
- 8.1.1 Parasiticide for Animal Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Parasiticide for Animal Production Mode & Process
- 8.2 Parasiticide for Animal Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Parasiticide for Animal Distributors
- 8.2.3 Parasiticide for Animal Customers
9 Global Parasiticide for Animal Analyzing Market Dynamics
- 9.1 Parasiticide for Animal Industry Trends
- 9.2 Parasiticide for Animal Industry Drivers
- 9.3 Parasiticide for Animal Industry Opportunities and Challenges
- 9.4 Parasiticide for Animal Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst